Kasım TURGUT, Erdal YAVUZ

Retrospective evaluation of patients who ingested drugsto commit suicide

Aim: To analyze patients presenting to our hospital after ingesting drugs for suicide purposes. Materials and Methods: Adult patients that attempted suicide by ingesting drugs or other substances were retrospectively reviewed over a two-year period. The population of the study was determined among the patients diagnosed with the ICD-10 codes of X.40- X49 in hospital records. The patients were divided into two groups as hospitalized and discharged, and evaluated in terms of age, gender, substances ingested, number of different types of drugs ingested, the statement of life threatening status in forensic reports, whether gastric lavage or activated charcoal was applied, history of previous suicide attempts, presence of psychiatric diagnoses, and leukocyte count. Then, we investigated any statistical differences between the two groups. Results: A total of 216 adult patients with a mean age of 27.65 ± 9.45 years were included in the study. The hospitalization rate was 49.1%. Taking two or more different types of drugs, a high leukocyte count, application of gastric lavage and active charcoal, and the presence of life-threatening status in forensic report were found to be higher in the hospitalized group(p 0.05). In addition, it was determined that for suicide purposes, psychiatric drugs were mostly taken by the patients with previous psychiatric diagnoses while those without these diagnoses mostly used analgesics to attempt suicide (p

PDF

___

1. Camidge DR, Wood RJ, Bateman DN. The epidemiology of self-poisoning in the UK. Br J Clin Pharmacol 2003;56:613-9.
2. Ramirez J. Suicide: Across the Life Span. Nurs Clin North Am 2016;51:275-86.
3. Wasserman D, Rihmer Z, Rujescu D, et al. The European Psychiatric Association (EPA) guidance on suicide treatment and prevention. Eur Psychiatry 2012;27:129-41.
4. Suicide in the World: Global Health Estimates. World Health Organization 2019.https://apps.who.int/iris/ handle/10665/326948
5. Zalar B, KoresPlesničar B, Zalar I, et al. Suicide and Sui¬cide Attemp Descriptors by Multimethod Approach. Psychi¬atr Danub 2018;30:317-22.
6. Zilker T. Akute Intoxikationen bei Erwachsenen - was Sie wissen sollten [Acute intoxication in adults - what you should know]. Dtsch Med Wochenschr 2014;139:31-46.
7. Demirkiran S, Celikel A. Forensic Case Management in Emergency Units. http://www.jcam.com.tr/files/ JCAM-4976.pdf
8. Karaca O, Ertaskin A. Epidemiology of Self-poisoning with Drug in the Central Anatolian Region in Turkey. Cureus 2020;12:e6962.
9. Goksu S, Yildirim C, Kocoglu H, et al. Characteristics of acute adult poisoning in Gaziantep, Turkey. J Toxicol Clin Toxicol 2002;40:833-7.
10. Isik GC, Safak T, Cetiner HS, et al. Evaluation of patients admitted to emergency department due to drugrelated suicide attempt. Eurasian J Tox 2020;2:11-4.
11. McCall WV, Benca RM, Rosenquist PB,et al. Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA. Am J Psychiatry 2017;174:18- 25.
12. Carter G, Reith DM, Whyte IM, et al. Repeated self poisoning: increasing severity of self harm as a predictor of subsequent suicide. Br J Psychiatry 2005;186:253-7.
13. Hossain S, Kabir F, Kamal S, et al. Cause and outcome of poisoning among admitted patients in a teaching hospital. Bangladesh Med J Khulna 2020;52:30-4.
14. Guneysu F, Saritas A. Analysis of Intoxication Due to Drug Intake. Eurasian J Tox 2019;1:109-12.
15. Pawlak JM, Miechowicz I, Dmitrzak-Węglarz M, et al. Are suicide risk factors gender specific? Psychiatr Pol 2018;52:21-32.
16. Parra-Uribe I, Blasco-Fontecilla H, Garcia-Parés G, et al. Risk of re-attempts and suicide death after a suicide attempt: A survival analysis. BMC Psychiatry 2017;17:163.
17. Leon AC. The revised warning for antidepressants and suicidality: unveiling the black box of statistical analyses. Am J Psychiatry 2007;164:1786-9.
18. Aguglia A, Serafini G, Solano P, et al. The role of seasonality and photoperiod on the lethality of suicide attempts: A case-control study. J Affect Disord 2019;246:895-901.